Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group

Marsh K, van Til JA, Molsen-David E, Juhnke C, Hawken N, Oehrlein EM, Choi YC, Duenas A, Greiner W, Haas K, Hiligsmann M, et al. (2020)
Value in health 23(7): 831-841.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Marsh, Kevin; van Til, Janine A; Molsen-David, Elizabeth; Juhnke, Christine; Hawken, Natalia; Oehrlein, Elisabeth M; Choi, Y Christy; Duenas, Alejandra; Greiner, WolfgangUniBi; Haas, Kara; Hiligsmann, Mickael; Hockley, Kimberley S
Alle
Abstract / Bemerkung
OBJECTIVE: This study examines European decision makers' consideration and use of quantitative preference data.; METHODS: The study reviewed quantitative preference data usage in 31 European countries to support marketing authorization, reimbursement, or pricing decisions. Use was defined as: agency guidance on preference data use, sponsor submission of preference data, or decision-maker collection of preference data. The data could be collected from any stakeholder using any method that generated quantitative estimates of preferences. Data were collected through: (1) documentary evidence identified through a literature and regulatory websites review, and via key opinion leader outreach; and (2) a survey of staff working for agencies that support or make healthcare technology decisions.; RESULTS: Preference data utilization was identified in 22 countries and at a European level. The most prevalent use (19 countries) was citizen preferences, collected using time-trade off or standard gamble methods to inform health state utility estimation. Preference data was also used to: (1) value other impact on patients, (2) incorporate non-health factors into reimbursement decisions, and (3) estimate opportunity cost. Pilot projects were identified (6 countries and at a European level), with a focus on multi-criteria decision analysis methods and choice-based methods to elicit patient preferences.; CONCLUSION: While quantitative preference data support reimbursement and pricing decisions in most European countries, there was no utilization evidence in European-level marketing authorization decisions. While there are commonalities, a diversity of usage was identified between jurisdictions. Pilots suggest the potential for greater use of preference data, and for alignment between decision makers. Copyright © 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.
Erscheinungsjahr
2020
Zeitschriftentitel
Value in health
Band
23
Ausgabe
7
Seite(n)
831-841
eISSN
1524-4733
Page URI
https://pub.uni-bielefeld.de/record/2945533

Zitieren

Marsh K, van Til JA, Molsen-David E, et al. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health. 2020;23(7):831-841.
Marsh, K., van Til, J. A., Molsen-David, E., Juhnke, C., Hawken, N., Oehrlein, E. M., Choi, Y. C., et al. (2020). Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health, 23(7), 831-841. doi:10.1016/j.jval.2019.11.009
Marsh, K., van Til, J. A., Molsen-David, E., Juhnke, C., Hawken, N., Oehrlein, E. M., Choi, Y. C., Duenas, A., Greiner, W., Haas, K., et al. (2020). Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health 23, 831-841.
Marsh, K., et al., 2020. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health, 23(7), p 831-841.
K. Marsh, et al., “Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group”, Value in health, vol. 23, 2020, pp. 831-841.
Marsh, K., van Til, J.A., Molsen-David, E., Juhnke, C., Hawken, N., Oehrlein, E.M., Choi, Y.C., Duenas, A., Greiner, W., Haas, K., Hiligsmann, M., Hockley, K.S., Ivlev, I., Liu, F., Ostermann, J., Poder, T., Poon, J.L., Muehlbacher, A.: Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health. 23, 831-841 (2020).
Marsh, Kevin, van Til, Janine A, Molsen-David, Elizabeth, Juhnke, Christine, Hawken, Natalia, Oehrlein, Elisabeth M, Choi, Y Christy, Duenas, Alejandra, Greiner, Wolfgang, Haas, Kara, Hiligsmann, Mickael, Hockley, Kimberley S, Ivlev, Ilya, Liu, Frank, Ostermann, Jan, Poder, Thomas, Poon, Jiat L, and Muehlbacher, Axel. “Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group”. Value in health 23.7 (2020): 831-841.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 32762984
PubMed | Europe PMC

Suchen in

Google Scholar